TFDA certified Jellox Biotech's 'MetaLite DX Digital Pathology Software' as SaMD
撰文GlobalBio & Investment
日期2024-01-25
TFDA certified Jellox Biotech's 'MetaLite DX Digital Pathology Software' as SaMD
Big kudos to Jellox Biotech for reaching a significant regulatory milestone! TFDA certified their 'MetaLite DX Digital Pathology Software' as #SaMD (Software as Medical Device) this month, marking it the first offline usable digital pathology product in Taiwan.
This achievement promises a wave of successful installations of JelloX solutions in the next-gen pathology field.
Read more:
https://news.gbimonthly.com/tw/article/show.php?num=64186
Follow #Globalbio for more groundbreaking news!
#JelloxBiotech #DigitalPathology #TFDA #TFDAApproval #MedicalInnovation
- © news.gbimonthly.com. All rights reserved. 環球生技版權所有,未經授權請勿轉載。授權合作請洽環球生技編輯部。